Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (17)

2024

  1. Dispersal history of SARS-CoV-2 in Galicia, Spain

    Journal of Medical Virology, Vol. 96, Núm. 7

2022

  1. An analysis of prognostic factors in a cohort of low-grade gliomas and degree of consistency between RTOG and EORTC scores

    Scientific Reports, Vol. 12, Núm. 1

  2. Limited genomic reconstruction of SARS-CoV-2 transmission history within local epidemiological clusters

    Virus Evolution, Vol. 8, Núm. 1

  3. SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression

    Microorganisms, Vol. 10, Núm. 1

2021

  1. Alterations in respiratory function test three months after hospitalisation for covid-19 pneumonia: Value of determining nitric oxide diffusion

    Journal of Clinical Medicine, Vol. 10, Núm. 10

2020

  1. Synthesis of silver and gold nanoparticles by Sargassum muticum biomolecules and evaluation of their antioxidant activity and antibacterial properties

    Journal of Nanostructure in Chemistry, Vol. 10, Núm. 4, pp. 317-330

2018

  1. Functional assessment of the BMPR2 gene in lymphoblastoid cell lines from Graves’ disease patients

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 3, pp. 1538-1547

2017

  1. Estudio de la prevalencia de marcadores genéticos asociados a la lenta progresión del virus de la inmunodeficiencia humana tipo 1 en la población gallega

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 2, pp. 104-107

2014

  1. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension

    PLoS ONE, Vol. 9, Núm. 6

  2. Viability of Lymph Node Samples Obtained by Echobronchoscopy in the Study of Epigenetic Alterations in Patients With Lung Cancer

    Archivos de Bronconeumologia, Vol. 50, Núm. 6, pp. 213-220

2012

  1. Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma

    Cancer Biology and Therapy, Vol. 13, Núm. 14, pp. 1436-1442

2011

  1. Clinical evaluation of two consanguineous families with homozygous mutations in BEST1

    Molecular Vision, Vol. 17, pp. 1607-1617

  2. N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians

    International Journal of Tuberculosis and Lung Disease, Vol. 15, Núm. 10, pp. 1403-1408

2010

  1. Letter to the editor

    Pharmacogenomics

2009

  1. Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to drug-induced liver injury

    Hepatology

2008

  1. Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population

    Liver International, Vol. 28, Núm. 6, pp. 835-839

2007

  1. Absence of activating mutations in the EGFR kinase domain in spanish head and neck cancer patients

    Tumor Biology, Vol. 28, Núm. 5, pp. 273-279